Cellular metabolism constrains innate immune responses in early human ontogeny.
Bernard KanChristina MichalskiHelen FuHilda H T AuKelsey LeeElizabeth A MarchantMaye F ChengEmily Anderson-BaucumMichal Aharoni-SimonPeter TilleyRaghavendra G MirmiraColin J D RossDan S LucianiEric JanPascal M LavoiePublished in: Nature communications (2018)
Pathogen immune responses are profoundly attenuated in fetuses and premature infants, yet the mechanisms underlying this developmental immaturity remain unclear. Here we show transcriptomic, metabolic and polysome profiling and find that monocytes isolated from infants born early in gestation display perturbations in PPAR-γ-regulated metabolic pathways, limited glycolytic capacity and reduced ribosomal activity. These metabolic changes are linked to a lack of translation of most cytokines and of MALT1 signalosome genes essential to respond to the neonatal pathogen Candida. In contrast, they have little impact on house-keeping phagocytosis functions. Transcriptome analyses further indicate a role for mTOR and its putative negative regulator DNA Damage Inducible Transcript 4-Like in regulating these metabolic constraints. Our results provide a molecular basis for the broad susceptibility to multiple pathogens in these infants, and suggest that the fetal immune system is metabolically programmed to avoid energetically costly, dispensable and potentially harmful immune responses during ontogeny.
Keyphrases
- immune response
- dna damage
- single cell
- dendritic cells
- rna seq
- candida albicans
- gestational age
- toll like receptor
- endothelial cells
- genome wide
- magnetic resonance
- type diabetes
- preterm infants
- computed tomography
- insulin resistance
- dna repair
- cystic fibrosis
- metabolic syndrome
- pseudomonas aeruginosa
- skeletal muscle
- preterm birth
- antimicrobial resistance
- contrast enhanced
- peripheral blood